⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 28, 2024Diagnostic PathologyOpen Access

Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations

Hisashi Tamada Takeshi Uehara Takahiro Yoshizawa Mai Iwaya Shiho Asaka Tomoyuki Nakajima Masato Kamakura Hiroyoshi Ota

View Full Paper

Ask AI

Bookmark

Share

Abstract

Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a cancer stem cell (CSC) marker of colorectal cancer and may be a CSC marker of other cancer types. Few studies have been conducted on LGR5 expression in extrahepatic cholangiocarcinoma (ECC).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tamada et al. (2024) studied this question.

synapsesocial.com/papers/68e5aa55b6db6435875440e6 https://doi.org/10.1186/s13000-024-01537-7

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1<i>LGR5</i> Expression Is Associated With Prognosis in High-Grade Hepatocellular Carcinoma2025
2Leucine‐rich repeat‐containing G protein‐coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications2024 · 4 citations
3LGR5 Expression in Lymph Node Metastases of Colorectal Cancer: Clinicopathological Insights and Prognostic Implications2024
4LGR5: from stem cell marker to therapeutic targetReview · 2026 · 3 citations
5LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transitionOriginal Research · 2017 · 26 citations